Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden.
JAMA Netw Open
; 4(12): e2136697, 2021 12 01.
Article
in English
| MEDLINE | ID: covidwho-1544185
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Severity of Illness Index
/
Rituximab
/
COVID-19
/
Hospitalization
/
Immunologic Factors
/
Multiple Sclerosis
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
English
Journal:
JAMA Netw Open
Year:
2021
Document Type:
Article
Affiliation country:
Jamanetworkopen.2021.36697
Similar
MEDLINE
...
LILACS
LIS